Ganga Pharmaceuticals Share Price
12.50+0.00 (+0.00%)
-14.38% past 1 Year
Corporate filings & documents
Announcements
Newspaper Publication in connection with the 37th Annual General Meeting of the Company
2 weeks agoNewspaper Publication in connection with the 37th Annual General Meeting of the Company
2 weeks agoThe Company has sent Letter to the Shareholder for aGM whose Email Id is not resgistered with the RTA
2 weeks agoThe Company has sent Letter to the Shareholder for aGM whose Email Id is not resgistered with the RTA
2 weeks agoPlease find enclosed herewith the Notice of the AGM for F.Y. 2025-26
2 weeks agoPlease find enclosed herewith the Notice of the AGM for F.Y. 2025-26
2 weeks agoPlease find enclosed herewith the Annual Report for F.Y. 2025-26
2 weeks agoPlease find enclosed herewith the Annual Report for F.Y. 2025-26
2 weeks agoIntimation for 37th Annual General Meeting Schedule to be held on Saturday September 26 2026
2 weeks agoIntimation for 37th Annual General Meeting Schedule to be held on Saturday September 26 2026
2 weeks agoCertificate in terms of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended June 2026
2 months agoCertificate in terms of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended June 2026
2 months agoNewspaper Publication regarding Special window for re-lodgement of transfer and dematerialisation request(s) of Physical securities
2 months agoNewspaper Publication regarding Special window for re-lodgement of transfer and dematerialisation request(s) of Physical securities
2 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year ended March 31 2026
3 months agoNon-Applicability of Annual Secretarial Compliance Report for the Financial Year ended March 31 2026
3 months agoAppointment of Secretarial Auditor
4 months agoAppointment of Secretarial Auditor
4 months agoAppointment of Internal Auditor
4 months agoAppointment of Internal Auditor
4 months agoAudited Financial Results of the Company for the half yeaar and financial year ended March 31 2026
4 months agoOutcome of the Board Meeting held on May 21 2026
4 months agoOutcome of the Board Meeting held on May 21 2026
4 months agoGanga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the half year and financial year ended March 31 2026.
4 months agoGanga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve the Audited Financial Results of the Company for the half year and financial year ended March 31 2026.
4 months agoCertificate in terms of Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026
5 months agoIntimation of Closure of Trading Window
5 months agoIntimation of Closure of Trading Window
5 months agoNewspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities
6 months agoNewspaper Publication regarding special window for re-lodgement of transfer and dematerialisation request(s) of physical securities
6 months agoRe-appointment of Mr. Bharat Brijmohan Sharma as Managing Director of the Company for a further period of Three year effective from April 01 2026
6 months agoRe-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01 2026
6 months agoRe-appointment of Mr. Bharat Brijmohan Sharma as Managing Director for a further period of Three years effective from April 01 2026
6 months agoCompliance Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018 for the quarter ended December 31 2025
8 months agoStatement of Deviation or Variation for the half year ended September 30 2025
10 months agoStatement of Deviation or Variation for the half year ended September 30 2025
10 months agoUn-audited financial results of the Company for the half year ended on September 30 2025
10 months agoOutcome of the Board Meeting pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 held on Friday November 07 2025
10 months agoGanga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the half year ended on September 30 2025
10 months agoCertificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended September 30 2025
11 months agoIntimation regarding closure of trading window
11 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavesh Dhirajlal Tanna
12 months agoThe Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhavesh Dhirajlal Tanna
12 months agoAnnual reports
Concalls & investor presentations
May 2024
ConcallPresentation